H. Müller

Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activity

J. Ball, S. K. Fehling, T. Strecker, 2020, npj Vaccines.

Mastomys natalensis papilloma virus (MnPV), the causative agent of epithelial proliferations: characterization of the virus particle.

L. Gissmann, H. Müller, 1978, The Journal of general virology.

Development and characterization of an indirect ELISA to detect SARS-CoV-2 spike protein-specific antibodies

L. Gieselmann, M. Eickmann, C. Rohde, 2021, Journal of Immunological Methods.

A rabies-specific human monoclonal antibody that protects mice against lethal rabies.

R. Köhler, K. Enssle, J. Hilfenhaus, 1991, Hybridoma.

Purified chick-embryo-cell (PCEC) rabies vaccine: its potency performance in different test systems and in humans.

E. Weinmann, H. Müller, R. Barth, 1990, Vaccine.

Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activity

J. Ball, S. K. Fehling, T. Strecker, 2020, npj Vaccines.

Variability of interferon-λ induction and antiviral activity in Nipah virus infected differentiated human bronchial epithelial cells of two human donors.

S. K. Fehling, T. Strecker, L. Sauerhering, 2017, Journal of General Virology.

Epidemiological study to detect active SARS-CoV-2 infections and seropositive persons in a selected cohort of employees in the Frankfurt am Main metropolitan area

S. Ciesek, C. Rohde, V. Krähling, 2020, medRxiv.

Inactivation of retroviruses in biologicals manufactured for human use.

T. Nowak, J. Hilfenhaus, Jens Peter Gregersen, 1991, Developments in biological standardization.